Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00250874
Status:
UNKNOWN
Last Update Posted:
2005-11-08
First Post:
2005-11-07
Brief Title:
Myocet Docetaxel Trastuzumab as 1st Line Treatment of Patients With HER-2Neu Positive Metastatic Breast Cancer
Sponsor:
Organization:
Zeneus Pharma